Biogen’s reckoning: How the Aduhelm debacle pushed a troubled company and its fractured leadership to the brink

 

The shocking revelation came in a Saturday afternoon email, restricted to a tight circle of top executives within Biogen. 

Al Sandrock, the company’s most prominent scientist and chief of its entire research and development group, was leaving. There was no warning or explanation. After 23 years at Biogen, Sandrock, 64, had apparently decided it was time to retire. Más

Ver

 Biogen Announces Alfred W. Sandrock, Jr. to Retire as Head of Research & Development